Publications by authors named "S Haroon"
Background: Obstructive sleep apnoea syndrome (OSAS) has been recognised as a potential risk factor for cognitive decline, yet its precise relationship with dementia remains uncertain. This study aimed to determine the risk of dementia among individuals with and without OSAS.
Methods: Data derived from 2.
Background: Patients, their family members and caregivers have firsthand experiences of living with or supporting someone living with a disease or medical condition. This knowledge by experience cannot be replaced by the knowledge acquired by clinicians, researchers, or other professionals through study and/or work. The Therapies for Long COVID in non-hospitalised individuals (TLC) research project was funded in the UK by the National Institute for Health and Care Research (NIHR) and UK Research and Innovation to investigate the impact of long COVID on affected individuals.
View Article and Find Full Text PDFBackground: The indoor home environment plays a crucial role in determining the outcome of respiratory diseases, including asthma. Researchers, clinicians, and patients would benefit from self-reported questionnaires to assess indoor home environmental exposures that may impact on respiratory health.
Objective: To review self-reported instruments for assessing indoor home environmental exposures in asthma patients and to characterise their content, development, and psychometric properties.
Background And Objectives: Cognitive impairment is common in haemodialysis patients and associated with adverse health outcomes. This may be due to cognitive impairments interfering with daily functioning and self-care, but evidence is limited. This cross-sectional study aims to explore the interrelationships between cognition and functional outcomes in haemodialysis patients.
View Article and Find Full Text PDFArticle Synopsis
- Pharmacogenomics (PGx) links genetic differences to drug responses, aiming to enhance treatment outcomes and minimize side effects, but it's underutilized in developing countries.
- Surveys conducted in Egypt and Lebanon revealed limited availability of PGx testing in healthcare facilities, with Egypt having some testing and Lebanon offering almost none.
- There is significant interest among pharmacists (over 34%) and physicians (almost 25%) in learning about PGx, with a consensus on the necessity for educational programs to improve PGx implementation in the Middle East.